DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) CEO Allan C. Thygesen sold 8,086 shares of the company’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $56.16, for a total transaction of $454,109.76. Following the sale, the chief executive officer now directly owns 99,546 shares of the company’s stock, valued at approximately $5,590,503.36. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
DocuSign Stock Up 2.5 %
DOCU stock traded up $1.46 during midday trading on Thursday, hitting $58.76. The company’s stock had a trading volume of 1,066,554 shares, compared to its average volume of 3,160,162. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76. The firm has a market capitalization of $12.07 billion, a price-to-earnings ratio of 162.95, a price-to-earnings-growth ratio of 4.89 and a beta of 0.88. The company has a 50 day moving average of $56.90 and a two-hundred day moving average of $53.06.
DocuSign (NASDAQ:DOCU – Get Free Report) last posted its quarterly earnings results on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. The business had revenue of $712.39 million during the quarter, compared to the consensus estimate of $698.05 million. On average, analysts anticipate that DocuSign, Inc. will post 0.87 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
DOCU has been the subject of several research reports. Morgan Stanley raised shares of DocuSign from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $49.00 to $64.00 in a research report on Tuesday, January 16th. JMP Securities reaffirmed a “market outperform” rating and set a $84.00 price target on shares of DocuSign in a research report on Friday, April 12th. UBS Group raised shares of DocuSign from a “sell” rating to a “neutral” rating and upped their price target for the company from $48.00 to $62.00 in a research report on Friday, April 12th. Wells Fargo & Company cut their price objective on DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research note on Monday, February 5th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $59.00 price objective on shares of DocuSign in a research note on Friday, April 12th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, DocuSign presently has a consensus rating of “Hold” and an average price target of $60.25.
Get Our Latest Research Report on DocuSign
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- About the Markup Calculator
- Meta Stock: 3 Reasons This Stumble Is a Golden Buying Opportunity
- Stock Dividend Cuts Happen Are You Ready?
- 3 Staples Stocks to Cushion Lower Consumer Sentiment
- What Makes a Stock a Good Dividend Stock?
- Zillow’s Earnings Dip: An Opportunity for Visionaries
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.